Detalhe da pesquisa
1.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36094839
2.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Lancet
; 402(10404): 798-808, 2023 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37451295
3.
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
J Eur Acad Dermatol Venereol
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38451047
4.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37875144
5.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36099927
6.
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
N Engl J Med
; 383(12): 1139-1148, 2020 09 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32877599
7.
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
J Transl Med
; 21(1): 265, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37072748
8.
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.
Future Oncol
; 19(30): 2017-2027, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37665297
9.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
J Dtsch Dermatol Ges
; 21(11): 1422-1433, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37840404
10.
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
N Engl J Med
; 381(7): 626-636, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31166680
11.
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 848-857, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34000246
12.
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Br J Cancer
; 124(3): 574-580, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33087895
13.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 395(10236): 1558-1568, 2020 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32416781
14.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29863979
15.
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study.
J Med Internet Res
; 23(2): e23436, 2021 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33528370
16.
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.
J Med Internet Res
; 23(7): e20708, 2021 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34255646
17.
[Local tumor control of metastatic Merkel cell carcinoma in a 90-year-old woman]. / Lokale Tumorkontrolle eines metastasierten Merkel-Zell-Karzinoms bei einer 90-jährigen Patientin.
Hautarzt
; 72(12): 1090-1093, 2021 Dec.
Artigo
Alemão
| MEDLINE | ID: mdl-33760961
18.
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial.
Lancet Oncol
; 21(3): 358-372, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32007138
19.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31952975
20.
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Br J Cancer
; 123(6): 885-897, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32713938